Literature DB >> 20830233

High-dose fentanyl patch for cancer pain of a patient with cholangiocarcinoma.

Jung Han Kim1, Mi Kim, Chong Won Sung, Hyeoung Su Kim, Hyun Joo Jang, Young Chul Shin, Joo Young Jung.   

Abstract

We describe here a patient who obtained a good analgesic effect with high-dose fentanyl patches for controlling cancer pain. A 52-year-old man was referred to our hospital because of severe cancer pain that was 7/10 on a numeric rating scale (NRS). He had been diagnosed with locally advanced cholangiocarcinoma 3 months previously. We prescribed weak opioids and an antidepressant, but his pain was not relieved. We introduced strong opioids (transdermal fentanyl patches for the background pain and a short-acting opioid for the breakthrough pain) and his pain was tolerable on 250 µg/hr of fentanyl patches for 3 months. With time, however, his pain intensity became worse and this reached up to 8/10 to 9/10 on the NRS. Percutaneous transhepatic biliary drainage was performed, which did not relieve his pain. We increased gradually the dose of transdermal fentanyl to 1,050 µg/hr (20 patches). At this dose, the patient was mentally alert, with good pain control (NRS 2/10 to 3/10) and no exacerbation of side effects. To the best of our knowledge, we report here on the highest dose of transdermal fentanyl that has been successfully used for treating a patient suffering from visceral cancer pain.

Entities:  

Keywords:  Cholangiocarcinoma; Fentanyl; Neoplasms; Pain

Mesh:

Substances:

Year:  2010        PMID: 20830233      PMCID: PMC2932949          DOI: 10.3904/kjim.2010.25.3.337

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  11 in total

1.  Long-term treatment of cancer pain with transdermal fentanyl.

Authors:  B Donner; M Zenz; M Strumpf; M Raber
Journal:  J Pain Symptom Manage       Date:  1998-03       Impact factor: 3.612

2.  Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report.

Authors:  C P Bleeker; R C Bremer; D A Dongelmans; R T van Dongen; B J Crul
Journal:  Eur J Pain       Date:  2001       Impact factor: 3.931

3.  Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region.

Authors:  S Grond; D Zech; K A Lehmann; L Radbruch; H Breitenbach; D Hertel
Journal:  Pain       Date:  1997-01       Impact factor: 6.961

4.  High dose morphine use in the hospice setting. A database survey of patient characteristics and effect on life expectancy.

Authors:  M Bercovitch; A Waller; A Adunsky
Journal:  Cancer       Date:  1999-09-01       Impact factor: 6.860

Review 5.  Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.

Authors:  R B Muijsers; A J Wagstaff
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.

Authors:  L Allan; H Hays; N H Jensen; B L de Waroux; M Bolt; R Donald; E Kalso
Journal:  BMJ       Date:  2001-05-12

7.  Patient-related barriers to management of cancer pain.

Authors:  Sandra E Ward; Nancy Goldberg; Vickie Miller-McCauley; Carol Mueller; Ann Nolan; Darlene Pawlik-Plank; Alice Robbins; Doris Stormoen; David E Weissman
Journal:  Pain       Date:  1993-03       Impact factor: 6.961

Review 8.  Management of pain in the cancer patient.

Authors:  T L Skaer
Journal:  Clin Ther       Date:  1993 Jul-Aug       Impact factor: 3.393

9.  Addition of a second opioid may improve opioid response in cancer pain: preliminary data.

Authors:  Sebastiano Mercadante; Patrizia Villari; Patrizia Ferrera; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2004-11       Impact factor: 3.603

10.  Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?

Authors:  Michaela Bercovitch; Abraham Adunsky
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

View more
  2 in total

1.  The Incidence of Severe Diarrhea with Transdermal Fentanyl Patch: An Uncommon Event.

Authors:  Karim Hemati; Poupak Rahim Zadeh
Journal:  J Clin Diagn Res       Date:  2015-06-01

2.  Efficacy of fentanyl transdermal patch in the treatment of chronic soft tissue cancer pain.

Authors:  Karim Hemati; Behrooz Zaman; Valliolah Hassani; Farnad Imani; Parviz Dariaie
Journal:  Anesth Pain Med       Date:  2015-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.